GlassScriptPhysician profile
Rami Sunallah
NPI 1588892582
$1,528.35
in general payments reported to CMS, 2019-2025
20 companies · $266 in 2025
The $266 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $81.43 · 2021: $222 · 2022: $290 · 2023: $293 · 2024: $212 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $350.85 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $182.67 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $141.68 | 2021-2025 | Qelbree |
| Tris Pharma INC | $137.90 | 2021-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $121.20 | 2023-2025 | |
| Seqirus USA INC | $97.59 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Pfizer INC. | $68.61 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $64.91 | 2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $60.82 | 2021 | |
| Merck Sharp & Dohme LLC | $48.96 | 2022-2024 | |
| Shire North American Group INC | $43.53 | 2019 | |
| Sobi, INC | $33.61 | 2022 | |
| Neos Therapeutics, LP | $31.57 | 2022-2025 | Cotempla Xr-Odt |
| Ultragenyx Pharmaceutical INC. | $27.69 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.04 | 2023-2024 | Flumist Quadrivalent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21.06 | 2025 | |
| Lnhc, INC | $20.57 | 2025 | Zelsuvmi |
| Collegium Pharmaceutical, INC. | $19.07 | 2025 | Jornay Pm |
| Corium, LLC | $14.66 | 2022 | |
| Verrica Pharmaceuticals INC. | $14.36 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Sunallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.